AU548904B2 - Indacrinone having enthanced uricosuric properties - Google Patents

Indacrinone having enthanced uricosuric properties

Info

Publication number
AU548904B2
AU548904B2 AU83854/82A AU8385482A AU548904B2 AU 548904 B2 AU548904 B2 AU 548904B2 AU 83854/82 A AU83854/82 A AU 83854/82A AU 8385482 A AU8385482 A AU 8385482A AU 548904 B2 AU548904 B2 AU 548904B2
Authority
AU
Australia
Prior art keywords
enthanced
indacrinone
uricosuric
properties
uricosuric properties
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU83854/82A
Other languages
English (en)
Other versions
AU8385482A (en
Inventor
Edward H. Blaine
Edward J. Cragoe
Ralph F. Hirschmann
John F. Nancarrow
Jonathan A. Tobert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU8385482A publication Critical patent/AU8385482A/en
Application granted granted Critical
Publication of AU548904B2 publication Critical patent/AU548904B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU83854/82A 1981-07-13 1982-05-19 Indacrinone having enthanced uricosuric properties Ceased AU548904B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28236081A 1981-07-13 1981-07-13
US282360 1981-07-13

Publications (2)

Publication Number Publication Date
AU8385482A AU8385482A (en) 1983-01-20
AU548904B2 true AU548904B2 (en) 1986-01-09

Family

ID=23081158

Family Applications (1)

Application Number Title Priority Date Filing Date
AU83854/82A Ceased AU548904B2 (en) 1981-07-13 1982-05-19 Indacrinone having enthanced uricosuric properties

Country Status (9)

Country Link
EP (1) EP0069846A1 (enExample)
JP (2) JPS5810516A (enExample)
AU (1) AU548904B2 (enExample)
CA (1) CA1179603A (enExample)
DK (1) DK223582A (enExample)
GR (1) GR78032B (enExample)
NZ (1) NZ200641A (enExample)
PT (1) PT74955B (enExample)
ZA (1) ZA823538B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1531221A (en) * 1974-09-02 1978-11-08 Smith Kline French Lab Process for preparing guanidine derivatives
US4693996A (en) * 1985-12-23 1987-09-15 Warner-Lambert Company Method of treating heart failure and medicaments therefor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7412823A (nl) * 1973-10-11 1975-04-15 Merck & Co Inc Werkwijze voor het bereiden van diuretisch ame preparaten en de door toepassing an verkregen voorwerpen.
PL98342B1 (pl) * 1974-07-30 1978-04-29 Sposob wytwarzania kwasu 1-keto-2-arylo-/lub tienylo/-2-podstawionego-indanyloksy-/lub tio/-5-alkanokarboksylowego
US4087542A (en) * 1975-07-09 1978-05-02 Merck & Co., Inc. 2,3-Dihydro-6,7-disubstituted-5-acyl benzofuran-2-carboxylic acids

Also Published As

Publication number Publication date
PT74955B (en) 1985-05-16
PT74955A (en) 1982-06-01
DK223582A (da) 1983-01-14
CA1179603A (en) 1984-12-18
JPS5946220A (ja) 1984-03-15
JPS5810516A (ja) 1983-01-21
ZA823538B (en) 1983-12-28
GR78032B (enExample) 1984-09-26
NZ200641A (en) 1985-12-13
AU8385482A (en) 1983-01-20
EP0069846A1 (en) 1983-01-19

Similar Documents

Publication Publication Date Title
AU551769B2 (en) Imidazodiazepines
AU551891B2 (en) Imidazodiazepines
AU551756B2 (en) Imidazodiazepines
AU561395B2 (en) 3-amino-benzazepin-2-ones
AU548397B2 (en) N-phenylsulphonyl-n:-pyrimidinyl-and-triazinyl-ureas
AU549409B2 (en) Polyetheresterimide
AU549410B2 (en) Polyetheresterimide
AU6184886A (en) Substituted phenoxypyridines
AU553589B2 (en) Benzoheterocycles
AU9087582A (en) Furan based foams
AU546185B2 (en) Levitationarium
AU551831B2 (en) Imidazodiazepines
AU547803B2 (en) s
AU557714B2 (en) 2-arylimidazopyridines
AU550571B2 (en) Co-nitration
AU547405B2 (en) Amidobenzamides
AU564233B2 (en) N-substituted-2-pyridylindoles
AU545678B2 (en) Sleeper-tamper
AU529966B2 (en) Washer-dehydrator
AU552046B2 (en) Imidazodiazepines
AU565320B2 (en) Pyridobenzodiazepines
AU556935B2 (en) Azolyl-pentene-3-ones and -3-ols
AU547692B2 (en) Trifluoromethylphenyltetrahydropyridines
AU557575B2 (en) 4-cyano-2-azetidinones
AU558041B2 (en) Tetrahydronaphthoxazoles